Comparative effectiveness of curettage, uterine artery embolization, and gonadotropin‐releasing hormone ( GnRH ) agonist therapy in the management of acquired uterine enhanced myometrial vascularity/arteriovenous malformation ( EMV / AVM ) and retained products of conception ( RPOC ): A retrospective cohort study

Key Points

• The study aims to compare the effectiveness of curettage, UAE, and GnRH agonist therapy in treating specific uterine conditions.
• Retrospective cohort study design
• Compared three treatment modalities: curettage, UAE, and GnRH agonist therapy
• Evaluated short-term healing and reproductive outcomes
• Considered Doppler parameters and clinical stability in treatment selection
• Curettage and UAE showed superior short-term healing compared to GnRH agonist therapy
• Reproductive outcomes were comparable across all treatment modalities
• Doppler parameters and clinical stability are important factors in treatment selection